Infracore (INFRAC.SW) traded down -0.58 % during a 24 hours period ending at 10:06 PM Central Europe on Monday 26th. One Infracore stock can currently be bought for about CHF 51 on popular exchanges. Current supply of Infracore stocks is 15.3 mn. Infracore has a current market capitalization of CHF 780.1 mn and approximately CHF 467 k worth of Infracore was traded on exchanges in the last 24 hours. Since last month end, Infracore has traded 3.98 % up. Simple moving average of last 200 days is at CHF 51. The highest price of past 52 weeks was recorded at CHF 54.49 on 07/09/2026. 52 weeks low was at CHF 48.1 on 10/12/2026.
Here is how related stocks have performed in the past 24 hours:
Lem (LEHN.SW) traded down -0.81 % and now trades at CHF 612. Lem has a market capitalisation of CHF 700.2 mn. Current price/earnings ratio for Lem is 41.77. LEM HOLDING SA reported its latest financial results for the quarter. The company’s earnings reflected steady revenue growth driven by its core manufacturing operations, while operating margins remained in line with prior periods. Management highlighted continued investment in production capacity and technology upgrades, emphasizing a focus on efficiency and cost control. The company’s guidance for the upcoming period signals a moderate expansion outlook, with expectations of sustaining growth momentum while managing the impact of global market volatility. Investor sentiment remained cautiously optimistic, with analysts noting the company’s solid fundamentals and its ability to navigate the evolving industrial landscape. No significant changes in dividend policy or share‑holder returns were announced, and the company reiterated its commitment to maintaining financial flexibility and supporting long‑term value creation.
Basilea Pharmaceutica (BSLN.SW) traded down -1.15 % and now trades at CHF 68.9. Basilea Pharmaceutica has a market capitalisation of CHF 850.8 mn. Basilea Pharmaceutica has a current price to earnings ratio of 17.11.
Glencore (GLEN.L) traded up 0.19 % and now trades at GBX 538.1. Glencore has a market capitalisation of GBX 84.4 bn. Glencore has a current price to earnings ratio of 15.86. GLENCORE PLC reported a robust 2026 financial year, with revenue and earnings reflecting a continued upward trend driven by a strong project pipeline across mining and energy sectors. The company maintained a solid cash position, supported by significant dividend payouts and a shareholder‑friendly dividend reinvestment plan. Operationally, GLENCORE achieved notable project completions and secured several high‑profile contracts, reinforcing its market presence. The board reaffirmed its commitment to environmental, social and governance standards, emphasizing safety, community engagement and workforce development. Risk management measures, including diversified client and commodity exposure, were highlighted as key to sustaining performance amid global commodity volatility. Overall, GLENCORE’s results suggest steady growth, a healthy balance sheet and a focus on long‑term value creation for shareholders.
Kuros Biosciences (KURN.SW) traded down -0.29 % and now trades at CHF 21. Kuros Biosciences has a market capitalisation of CHF 807.1 mn. Kuros Biosciences has a current price to earnings ratio of 113.84.
Aebi Schmidt (AEBI) traded down -1.25 % and now trades at USD 11.13. Current market capitalisation for Aebi Schmidt is USD 857.5 mn.
